<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
______________
SCHEDULE 13G
(RULE 13D-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED
PURSUANT TO RULES 13d-1(b) AND (c) AND
AMENDMENTS THERETO FILED PURSUANT TO 13d-2(b)
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. ____)/1/
NexMed, Inc.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $0.001 par value per share
- --------------------------------------------------------------------------------
(Title of Class of Securities)
652903 10 5
-----------
(CUSIP Number)
- -----------------
/1/ The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
<PAGE>
CUSIP No. 652903 10 5 13G Page 2 of 6 Pages
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
CDC Venture Investment (Asia) Limited
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_]
(b) [_]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
British Virgin Islands
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF
500,000
SHARES
6 SHARED VOTING POWER
BENEFICIALLY
0
OWNED BY
7 SOLE DISPOSITIVE POWER
EACH
500,000
REPORTING
8 SHARED DISPOSITIVE POWER
PERSON WITH
0
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
500,000
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
(b) [_]
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
8.1%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
CO
- --------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE>
CUSIP No. 652903 10 5 13G Page 3 of 6 Pages
ITEM 1(a). NAME OF ISSUER:
NexMed, Inc.
ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
350 Corporate Boulevard
Robbinsville, New Jersey 08691
ITEM 2(a). NAME OF PERSON FILING:
CDC Venture Investment (Asia) Limited
ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:
11th Floor, CDC Tower
125 Nanking East Road, Sec. 5
Taipei 10572, Taiwan
ITEM 2(c). CITIZENSHIP:
British Virgin Islands
ITEM 2(d). TITLE OF CLASS OF SECURITIES:
Common Stock, $0.001 par value per share
ITEM 2(e). CUSIP NUMBER:
652903 10 5
<PAGE>
CUSIP No. 652903 10 5 13G Page 4 of 6 Pages
ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULES
13d-1(b), OR 13d-2(b) CHECK WHETHER THE PERSON
FILLING IS A:
Not applicable.
ITEM 4. OWNERSHIP.
(a) Amount beneficially owned:
500,000
(b) Percent of class:
8.1%
(c) Number of shares as to which such person has:
<TABLE>
<S> <C>
(i) Sole power to vote or to
direct the vote 500,000
-------
(ii) Shared power to vote or to
direct the vote 0
-------
(iii) Sole power to dispose or to
direct the disposition of 500,000
-------
(iv) Shared power to dispose or to
direct the disposition of 0
-------
</TABLE>
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.
If this statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of more than
five percent of the class of securities check the following. [_]
<PAGE>
CUSIP No. 652903 10 5 13G Page 5 of 6 Pages
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.
Not applicable.
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED
THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY.
Not applicable.
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.
Not applicable.
ITEM 9. NOTICE OF DISSOLUTION OF GROUP.
Not applicable.
ITEM 10. CERTIFICATION.
Not applicable.
<PAGE>
CUSIP No. 652903 10 5 13G Page 6 of 6 Pages
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
February 13, 1998
---------------------------------
Date
CDC VENTURE INVESTMENT (ASIA) LIMITED
BY: /s/ Brian C. Keng
---------------------------------
Brian C. Keng, Director
